Accuzide Filmtabletten and Accuzide forte Filmtabletten
Recall
|
Medicines
|
08/03/2022
The marketing authorisation holder informed its customers on March 07, 2022, that the nitrosamine levels of the listed batches are above the permitted acceptable daily dose.
For that reason, the affected batches are recalled as a precautionary measure.
| Name of the medicinal product | 1) Accuzide Filmtabletten 2) Accuzide forte Filmtabletten |
|---|---|
| Marketing authorisation number(s) | 1) 1-20206 2) 1-20208 |
| CIP code | 1) 1276810 2) 1276827 |
| Marketing authorisation holder | Pfizer Corporation Austria GmbH |
| Batch number(s) | 1) Batch, Expiry Date DK4164, 31.10.2022 DT1721, 31.10.2022 FK8589, 31.07.2023 2) Batch, Expiry Date CK1702, 30.04.2022 ET1542, 31.10.2022 FM6658, 31.08.2024 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3795 |
Further inquiry note
Page last modified:
07/03/2022